IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $660,000 | +4.9% | 12,200 | 0.0% | 0.02% | +46.7% |
| Q3 2018 | $629,000 | -12.2% | 12,200 | -29.1% | 0.02% | -16.7% |
| Q2 2018 | $716,000 | -5.5% | 17,200 | 0.0% | 0.02% | -18.2% |
| Q1 2018 | $758,000 | -12.4% | 17,200 | 0.0% | 0.02% | -12.0% |
| Q4 2017 | $865,000 | -1.9% | 17,200 | -1.1% | 0.02% | -3.8% |
| Q3 2017 | $882,000 | +0.8% | 17,400 | +1.2% | 0.03% | -10.3% |
| Q2 2017 | $875,000 | +26.6% | 17,200 | 0.0% | 0.03% | +31.8% |
| Q1 2017 | $691,000 | -16.0% | 17,200 | 0.0% | 0.02% | -18.5% |
| Q4 2016 | $823,000 | +30.6% | 17,200 | 0.0% | 0.03% | +50.0% |
| Q3 2016 | $630,000 | +57.1% | 17,200 | 0.0% | 0.02% | +80.0% |
| Q2 2016 | $401,000 | -41.7% | 17,200 | +1.2% | 0.01% | -41.2% |
| Q1 2016 | $688,000 | -34.7% | 17,000 | 0.0% | 0.02% | -26.1% |
| Q4 2015 | $1,053,000 | – | 17,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |